肺癌治疗中若干热点问题的探讨

被引：19

作者：

韩宝惠

机构：

[1] 上海市胸科医院肺内科

来源：

临床肿瘤学杂志 | 2007年 / 10期

关键词：

肺癌; 治疗;

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100117 [系统生物医学];

摘要：

引用

页码：721 / 727

页数：7

共 6 条

[1]

Bevacizumab and non-small-cell lung cancer.[J].Grossi;Aita.Expert Opinion on Biological Therapy.2007, 7

[2]

Angiogenesis inhibitors in the treatment of lung cancer [J].

Sun, Sophie ;

Schiller, Joan H. .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 62 (02) :93-104

[3]

Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going [J].

Rosell, R ;

Cuello, M ;

Cecere, F ;

Santarpia, M ;

Reguart, N ;

Felip, E ;

Taron, M .

CURRENT OPINION IN ONCOLOGY, 2006, 18 (02) :135-143

[4]

Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer.[J].Rafael Rosell;Frank Fossella;Luka Milas.Lung Cancer.2002,

[5]

Chemotherapy In Non-Small Cell Lung Cancer: A Meta-Analysis Using Updated Data On Individual Patients From 52 Randomised Clinical Trials.[J]..BMJ: British Medical Journal.1995, 7010

[6]

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in Stages IIIa and IIIb nonsmall cell lung cancer: A meta-analysis.[J]..Lung Cancer.1995, 3

← 1 →